{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:10:26Z","timestamp":1759403426910,"version":"build-2065373602"},"reference-count":21,"publisher":"Elsevier BV","issue":"35","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005860","name":"Helsefonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005860","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008363","name":"Kr\u00e6ftens Bek\u00e6mpelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.vaccine.2020.06.057","type":"journal-article","created":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T17:44:57Z","timestamp":1593711897000},"page":"5678-5684","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Are unexplained adverse health events following HPV vaccination associated with infectious mononucleosis? \u2013 A Danish nationwide matched case-control study"],"prefix":"10.1016","volume":"38","author":[{"given":"Lene Wulff","family":"Krogsgaard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ida Glode","family":"Helmuth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bodil Hammer","family":"Bech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oleguer","family":"Plana-Ripoll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tina Hovgaard","family":"L\u00fctzen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanne Thang","family":"Vestergaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karsten Dalsgaard","family":"Bjerre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reimar Wernich","family":"Thomsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3100-4990","authenticated-orcid":false,"given":"K\u00e5re","family":"M\u00f8lbak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1518-0975","authenticated-orcid":false,"given":"Dorte","family":"Rytter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.06.057_b0005","unstructured":"Statens Serum Institut. EPI news n.d.; 2020. https:\/\/en.ssi.dk\/news\/epi-news\/2016\/no-17---2016."},{"key":"10.1016\/j.vaccine.2020.06.057_b0010","unstructured":"Danish Health and Medicines Authority. Report from the Danish Health and Medicines Authority for consideration by EMA and rapporteurs in relation to the assessment of the safety profile of HPV-vaccines; 2015."},{"key":"10.1016\/j.vaccine.2020.06.057_b0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162520","article-title":"Pre-vaccination care-seeking in females reporting severe adverse reactions to HPV vaccine. A registry based case-control study","volume":"11","author":"Molbak","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2020.06.057_b0020","first-page":"18","article-title":"Decline in HPV-vaccination uptake in Denmark - The association between HPV-related media coverage and HPV-vaccination","author":"Suppli","year":"2018","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2020.06.057_b0025","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1016\/j.vaccine.2017.06.031","article-title":"HPV vaccination and risk of chronic fatigue syndrome\/myalgic encephalomyelitis: A nationwide register-based study from Norway","volume":"35","author":"Feiring","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.06.057_b0030","doi-asserted-by":"crossref","unstructured":"Arbyn M, Xu L, Simoens C, Martin-Hirsch PP. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors. Cochrane Database Syst Rev 2018;5:CD009069. https:\/\/doi.org\/10.1002\/14651858.CD009069.pub3 [doi].","DOI":"10.1002\/14651858.CD009069.pub3"},{"key":"10.1016\/j.vaccine.2020.06.057_b0035","doi-asserted-by":"crossref","DOI":"10.1093\/aje\/kwz284","article-title":"Hospital records of pain, fatigue, or circulatory symptoms in girls exposed to human papillomavirus vaccination: Cohort, self-controlled case series, and population time trend studies","author":"Thomsen","year":"2020","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2020.06.057_b0040","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/joim.12694","article-title":"Human papillomavirus vaccination of adult women and risk of autoimmune and neurological diseases","volume":"283","author":"Hviid","year":"2018","journal-title":"J Intern Med"},{"key":"10.1016\/j.vaccine.2020.06.057_b0045","unstructured":"European Medicines Agency. HPV vaccines: EMA confirms evidence does not support that they cause CRPS or POTS, vol. 44; 2015."},{"key":"10.1016\/j.vaccine.2020.06.057_b0050","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.vaccine.2008.10.043","article-title":"Vaccination as teenagers against meningococcal disease and the risk of the chronic fatigue syndrome","volume":"27","author":"Magnus","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.06.057_b0055","article-title":"Principles and practice of infectious diseases. vol. 35. 7 edition","author":"Tigertt","year":"1986","journal-title":"Churchill Livingstone"},{"key":"10.1016\/j.vaccine.2020.06.057_b0060","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0095-4543(21)00177-9","article-title":"Infectious mononucleosis","volume":"2","author":"Hoagland","year":"1975","journal-title":"Prim Care - Clin Off Pract"},{"key":"10.1016\/j.vaccine.2020.06.057_b0065","first-page":"141","article-title":"Infectious mononucleosis","volume":"137","author":"Papadakis","year":"1982","journal-title":"West J Med"},{"key":"10.1016\/j.vaccine.2020.06.057_b0070","unstructured":"Brinth L, Theibel AC, Pors K, Mehlsen J. Suspected side effects to the quadrivalent human papilloma vaccine. Dan Med J 2015;62:A5064. https:\/\/doi.org\/A5064 [pii]."},{"key":"10.1016\/j.vaccine.2020.06.057_b0075","first-page":"17","article-title":"The Danish vaccination register","author":"Grove Krause","year":"2012","journal-title":"Euro Surveill Bull Eur Sur Les Mal Transm = Eur Commun Dis Bull"},{"key":"10.1016\/j.vaccine.2020.06.057_b0080","doi-asserted-by":"crossref","unstructured":"Voldstedlund M, Haarh M, M\u00f8lbak K. The danish microbiology database (MIBA) 2010 to 2013. Eurosurveillance 2014;19. https:\/\/doi.org\/10.2807\/1560-7917.ES2014.19.1.20667.","DOI":"10.2807\/1560-7917.ES2014.19.1.20667"},{"key":"10.1016\/j.vaccine.2020.06.057_b0085","doi-asserted-by":"crossref","unstructured":"European medicines agency. ICH E2A - Clinincal Safety Data Managements: Definitions and Standards for Expedited Reporting, vol. 23; 2010. https:\/\/doi.org\/10.1358\/dnp.2010.23.1.1437303.","DOI":"10.1358\/dnp.2010.23.1.1437303"},{"key":"10.1016\/j.vaccine.2020.06.057_b0090","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2147\/CLEP.S135318","article-title":"Psychiatric conditions and general practitioner attendance prior to HPV vaccination and the risk of referral to a specialized hospital setting because of suspected adverse events following HPV vaccination: a register-based, matched case-control study","volume":"9","author":"Lutzen","year":"2017","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.vaccine.2020.06.057_b0095","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/j.vaccine.2019.02.029","article-title":"Hospital contacts and diagnoses five years prior to HPV vaccination among females referred for suspected adverse vaccine effects: A Danish nationwide case-control study","volume":"37","author":"Krogsgaard","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.06.057_b0100","doi-asserted-by":"crossref","unstructured":"Statens serum Institut. EPI News Week 16\/17 2019 2019;2020. https:\/\/en.ssi.dk\/news\/epi-news\/2019\/no-16-17---2019.","DOI":"10.22233\/20412495.0319.16"},{"key":"10.1016\/j.vaccine.2020.06.057_b0105","doi-asserted-by":"crossref","first-page":"908","DOI":"10.3109\/23744235.2015.1082036","article-title":"Clinical characteristics and laboratory findings in Danish children hospitalized with primary Epstein-Barr virus infection","volume":"47","author":"Topp","year":"2015","journal-title":"Infect Dis (Auckl)"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20308434?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20308434?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:44:15Z","timestamp":1759401855000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20308434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":21,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0264410X20308434"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.06.057","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Are unexplained adverse health events following HPV vaccination associated with infectious mononucleosis? \u2013 A Danish nationwide matched case-control study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.06.057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}